High human immunodeficiency virus type 1 RNA load in the cerebrospinal fluid from patients with lymphocytic meningitis

被引:51
作者
Morris, L
Silber, E
Sonnenberg, P
Eintracht, S
Nyoka, S
Lyons, SF
Saffer, D
Koornhof, H
Martin, DJ
机构
[1] Univ Witwatersrand, Dept Virol, Natl Inst Virol, MRC,AIDS Virus Res Unit, Johannesburg, South Africa
[2] Univ Witwatersrand, Dept Community Hlth, ZA-2001 Johannesburg, South Africa
[3] Baragwanath Hosp, Dept Neurol, ZA-2013 Johannesburg, South Africa
[4] S African Inst Med Res, Dept Chem Pathol, Johannesburg, South Africa
[5] S African Inst Med Res, Dept Med Microbiol, Johannesburg, South Africa
关键词
D O I
10.1086/517379
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Thirty-seven matched cerebrospinal fluid (CSF) and plasma samples from 34 human immunodeficiency virus type 1 (HIV-1)-infected patients with suspected meningitis were analyzed for levels of HIV-1 RNA and markers of inflammation, Patients with tuberculous (n = 9) or cryptococcal (n = 6) meningitis had the highest CSF virus loads, which in many cases exceeded the levels in plasma, compared with patients with meningococcal meningitis (n = 3), aseptic meningitis (n = 8), tuberculoma (n = 2), or AIDS dementia complex (n = 4) or with normal lumbar punctures (n = 3), CSF virus load correlated significantly with the number of infiltrating lymphocytes (r = .60, P < .001) but not with plasma virus load, the levels of beta(2)-microglobulin in the CSF, or the integrity of the blood-brain barrier. These data suggest significant intrathecal HIV-1 replication in patients with lymphocytic meningeal infections such as tuberculous and cryptococcal meningitis.
引用
收藏
页码:473 / 476
页数:4
相关论文
共 15 条
[1]   Levels of human immunodeficiency virus type 1 RNA in cerebrospinal fluid correlate with AIDS dementia stage [J].
Brew, BJ ;
Pemberton, L ;
Cunningham, P ;
Law, MG .
JOURNAL OF INFECTIOUS DISEASES, 1997, 175 (04) :963-966
[2]   HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 IS PRESENT IN THE CEREBROSPINAL-FLUID OF A MAJORITY OF INFECTED INDIVIDUALS [J].
CHIODI, F ;
KEYS, B ;
ALBERT, J ;
HAGBERG, L ;
LUNDEBERG, J ;
UHLEN, M ;
FENYO, EM ;
NORKRANS, G .
JOURNAL OF CLINICAL MICROBIOLOGY, 1992, 30 (07) :1768-1771
[3]   QUANTIFYING HIV-1 RNA USING THE POLYMERASE CHAIN-REACTION ON CEREBROSPINAL-FLUID AND SERUM OF SEROPOSITIVE INDIVIDUALS WITH AND WITHOUT NEUROLOGIC ABNORMALITIES [J].
CONRAD, AJ ;
SCHMID, P ;
SYNDULKO, K ;
SINGER, EJ ;
NAGRA, RM ;
RUSSELL, JJ ;
TOURTELLOTTE, WW .
JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES AND HUMAN RETROVIROLOGY, 1995, 10 (04) :425-435
[4]  
DECOCK KM, 1992, JAMA-J AM MED ASSOC, V268, P1581, DOI 10.1001/jama.1992.03490120095035
[5]   EXPRESSION OF HIV-1 IN THE CEREBROSPINAL-FLUID DETECTED BY THE POLYMERASE CHAIN-REACTION AND ITS CORRELATION WITH CENTRAL-NERVOUS-SYSTEM DISEASE [J].
GOSWAMI, KK ;
MILLER, RF ;
HARRISON, MJ ;
HAMEL, DJ ;
DANIELS, RS ;
TEDDER, RS .
AIDS, 1991, 5 (07) :797-803
[6]  
LEDERMAN MM, 1994, J ACQ IMMUN DEF SYND, V7, P727
[7]   NEUROLOGIC DISEASES ASSOCIATED WITH HIV-1 INFECTION [J].
MCARTHUR, JC .
CURRENT OPINION IN INFECTIOUS DISEASES, 1995, 8 (01) :74-84
[8]   Prognosis in HIV-1 infection predicted by the quantity of virus in plasma [J].
Mellors, JW ;
Rinaldo, CR ;
Gupta, P ;
White, RM ;
Todd, JA ;
Kingsley, LA .
SCIENCE, 1996, 272 (5265) :1167-1170
[9]   ENHANCEMENT OF HIV-1 INFECTION BY THE CAPSULAR POLYSACCHARIDE OF CRYPTOCOCCUS-NEOFORMANS [J].
PETTOELLOMANTOVANI, M ;
CASADEVALL, A ;
KOLLMANN, TR ;
RUBINSTEIN, A ;
GOLDSTEIN, H .
LANCET, 1992, 339 (8784) :21-23
[10]   Virologic markers of human immunodeficiency virus type 1 in cerebrospinal fluid of infected children [J].
Pratt, RD ;
Nichols, S ;
McKinney, N ;
Kwok, S ;
Dankner, WM ;
Spector, SA .
JOURNAL OF INFECTIOUS DISEASES, 1996, 174 (02) :288-293